Stock Events

Stock Events

Sonnet Biotherapeutics (SONN) Q1 2023 Earnings

10MayConfirmed

Aug 22

Dec 22

Q4 2022

Q1 2023

-1.96

-1.42

-0.88

-0.34

Details

Expected EPS

N/A

Actual EPS

-0.34

Surprise EPS

-0.34

Surprise Percent

+∞%

Description

Sonnet Biotherapeutics (SONN) has reported earnings of -0.34 per share for Q1 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.